Where neurostimulation meets neurodegeneration in Parkinson's disease related to GBA variants.
作者信息
Shih Ludy C, O'Connor Margaret
机构信息
Department of Neurology, Boston Medical Center, Boston, Massachusetts, USA.
Department of Neurology, Chobanian and Avedisian Boston University School of Medicine, Boston, Massachusetts, USA.
出版信息
Ann Clin Transl Neurol. 2024 Apr;11(4):840-841. doi: 10.1002/acn3.52012. Epub 2024 Mar 26.
Abstract
摘要
相似文献
1
Where neurostimulation meets neurodegeneration in Parkinson's disease related to GBA variants.在与GBA变异相关的帕金森病中，神经刺激与神经退行性变的关联之处。
Ann Clin Transl Neurol. 2024 Apr;11(4):840-841. doi: 10.1002/acn3.52012. Epub 2024 Mar 26.
2
Role of Lysosomal Gene Variants in Modulating GBA-Associated Parkinson's Disease Risk.溶酶体基因变异在调节 GBA 相关帕金森病风险中的作用。
Mov Disord. 2022 Jun;37(6):1202-1210. doi: 10.1002/mds.28987. Epub 2022 Mar 9.
3
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
4
Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.与 GBA 突变和帕金森病相关的视觉短期记忆缺陷。
Brain. 2014 Aug;137(Pt 8):2303-11. doi: 10.1093/brain/awu143. Epub 2014 Jun 11.
5
Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.转 Gaucher 突变杂合子帕金森病小鼠表型增强。
Brain. 2014 Dec;137(Pt 12):3235-47. doi: 10.1093/brain/awu291. Epub 2014 Oct 27.
6
Mutations in glucocerebrosidase are a major genetic risk factor for Parkinson's disease and increase susceptibility to dementia in a Flanders-Belgian cohort.葡萄糖脑苷脂酶突变是帕金森病的主要遗传风险因素，在一个佛兰德 - 比利时队列中会增加患痴呆症的易感性。
Neurosci Lett. 2016 Aug 26;629:160-164. doi: 10.1016/j.neulet.2016.07.008. Epub 2016 Jul 7.
7
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.帕金森进展标志物倡议（PPMI）中无明显 LRRK2 和 GBA 突变携带者的临床和多巴胺转运体成像特征：一项横断面研究。
Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.
8
Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease.葡萄糖脑苷脂酶多态性和突变与帕金森病发病后痴呆的关联。
Alzheimers Dement. 2018 Oct;14(10):1293-1301. doi: 10.1016/j.jalz.2018.04.006. Epub 2018 May 21.
9
Parkinson's Clustering in Families of Non-Neuronopathic N370S GBA Mutation Carriers Indicates the Presence of Genetic Modifiers.帕金森病在非神经病变 N370S GBA 突变携带者的家族中聚集表明存在遗传修饰因子。
J Parkinsons Dis. 2021;11(2):615-618. doi: 10.3233/JPD-202422.
10
GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.GBA 相关帕金森病：深部脑刺激队列的进展。
J Parkinsons Dis. 2017;7(4):635-644. doi: 10.3233/JPD-171172.
本文引用的文献
1
NIH Toolbox performance of persons with Parkinson's disease according to GBA1 and STN-DBS status.NIH 工具包在帕金森病患者中的表现，根据 GBA1 和 STN-DBS 状态。
Ann Clin Transl Neurol. 2024 Apr;11(4):899-904. doi: 10.1002/acn3.52005. Epub 2024 Feb 9.
2
Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers.帕金森病与丘脑底核脑深部电刺激：GBA 基因突变携带者的认知影响。
Ann Neurol. 2022 Mar;91(3):424-435. doi: 10.1002/ana.26302. Epub 2022 Jan 25.
3
Parkinson disease-associated cognitive impairment.帕金森病相关认知障碍。
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3.
4
Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson's disease.帕金森病患者接受内侧苍白球或丘脑底核深部脑刺激3年后的认知和精神状态结果
Parkinsonism Relat Disord. 2016 Dec;33:90-95. doi: 10.1016/j.parkreldis.2016.09.018. Epub 2016 Sep 19.
5
Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation.帕金森病的基因型和表型：深部脑刺激的异质性启示。
Mov Disord. 2013 Sep;28(10):1370-5. doi: 10.1002/mds.25535. Epub 2013 Jul 1.
6
Glucocerebrosidase mutations influence the natural history of Parkinson's disease in a community-based incident cohort.葡萄糖脑苷脂酶突变影响基于社区的发病队列中帕金森病的自然史。
Brain. 2013 Feb;136(Pt 2):392-9. doi: 10.1093/brain/aws318.
7
Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.随机对照试验深部脑刺激治疗帕金森病：36 个月的结果。
Neurology. 2012 Jul 3;79(1):55-65. doi: 10.1212/WNL.0b013e31825dcdc1. Epub 2012 Jun 20.
8
Cognitive performance of GBA mutation carriers with early-onset PD: the CORE-PD study.早发性帕金森病 GBA 突变携带者的认知表现：CORE-PD 研究。
Neurology. 2012 May 1;78(18):1434-40. doi: 10.1212/WNL.0b013e318253d54b. Epub 2012 Mar 21.
Zotero 插件